0001562762-18-000281.txt : 20180830
0001562762-18-000281.hdr.sgml : 20180830
20180830121509
ACCESSION NUMBER: 0001562762-18-000281
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20180830
DATE AS OF CHANGE: 20180830
EFFECTIVENESS DATE: 20180830
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: PAIN THERAPEUTICS INC
CENTRAL INDEX KEY: 0001069530
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 911911336
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-320389
FILM NUMBER: 181046252
BUSINESS ADDRESS:
STREET 1: 7801 N CAPITAL OF TEXAS HIGHWAY
STREET 2: SUITE 260
CITY: AUSTIN
STATE: TX
ZIP: 78731
BUSINESS PHONE: 512-501-2444
MAIL ADDRESS:
STREET 1: 7801 N CAPITAL OF TEXAS HIGHWAY
STREET 2: SUITE 260
CITY: AUSTIN
STATE: TX
ZIP: 78731
D
1
primary_doc.xml
X0708
D
LIVE
0001069530
PAIN THERAPEUTICS INC
7801 N CAPITAL OF TEXAS HIGHWAY
SUITE 260
AUSTIN
TX
TEXAS
78731
512-501-2444
DELAWARE
None
None
Corporation
true
Remi
Barbier
7801 N. Capital of Texas Highway
Suite 260
Austin
TX
TEXAS
78731
Executive Officer
Director
Nadav
Friedmann
7801 N. Capital of Texas Highway
Suite 260
Austin
TX
TEXAS
78731
Executive Officer
Director
Robert
Gussin
7801 N. Capital of Texas Highway
Suite 260
Austin
TX
TEXAS
78731
Director
Michael
O'Donnell
7801 N. Capital of Texas Highway
Suite 260
Austin
TX
TEXAS
78731
Director
Saira
Ramasastry
7801 N. Capital of Texas Highway
Suite 260
Austin
TX
TEXAS
78731
Director
Sanford
Robertson
7801 N. Capital of Texas Highway
Suite 260
Austin
TX
TEXAS
78731
Director
Patrick
Scannon
7801 N. Capital of Texas Highway
Suite 260
Austin
TX
TEXAS
78731
Director
Pharmaceuticals
Decline to Disclose
- 06b
false
2018-08-15
false
true
true
false
0
H.C. Wainwright & Co., LLC
375
None
None
430 Park Avenue
New York
NY
NEW YORK
10022
AL
ALABAMA
CA
CALIFORNIA
IL
ILLINOIS
NJ
NEW JERSEY
NY
NEW YORK
false
1107597
1107597
0
false
13
77531
0
The issuer will pay a cash fee to H.C. Wainwright equal to 7.00% of the aggregate gross proceeds raised.
0
false
PAIN THERAPEUTICS INC
/S/ Remi Barbier
Remi Barbier
President and Chief Executive Officer
2018-08-30